Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells

Respirology

Volumn 18, Issue , 2013, Pages 30-39

  Yin, Yan ^a   Hou, Gang ^a   Li, Er Ran ^a   Wang, Qiu Yue ^a   Kang, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bronchial epithelial cell; Cigarette smoke; Nuclear factor kappa B; Peroxisome proliferator activated receptor ; Tolllike receptor 4

Indexed keywords

BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; CIGARETTE SMOKE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LEUKOTRIENE B4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TOLL LIKE RECEPTOR 4; 2,2 BIS(4 GLYCIDYLOXYPHENYL)PROPANE; 2,2-BIS(4-GLYCIDYLOXYPHENYL)PROPANE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; BENZHYDRYL DERIVATIVE; EPOXIDE; TLR4 PROTEIN, RAT;

AIRWAY EPITHELIUM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIAL EPITHELIAL CELL; BRONCHUS EPITHELIUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFLAMMATION; WESTERN BLOTTING; ANIMAL; BRONCHUS; CELL CULTURE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; METABOLISM; NUCLEAR FACTOR-KAPPA B; PATHOLOGY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Γ; PNEUMONIA; SMOKING; UPREGULATION; WISTAR RAT;

BRONCHIAL EPITHELIAL CELL; CIGARETTE SMOKE; NUCLEAR FACTOR-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Γ; TOLL-LIKE RECEPTOR 4;

ANIMALS; BENZHYDRYL COMPOUNDS; BRONCHI; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPITHELIAL CELLS; EPOXY COMPOUNDS; INTERLEUKIN-8; LEUKOTRIENE B4; MALE; NF-KAPPA B; PNEUMONIA; PPAR GAMMA; RATS; RATS, WISTAR; SMOKING; THIAZOLIDINEDIONES; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84896318516     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12167     Document Type: Article

References (34)

1. Caito S, Yang SR, Kode A et al. Rosiglitazone and 15-deoxydelta12, 14-prostaglandin J2, PPAR gamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages. Antioxid. Redox Signal. 2008; 10: 253-60.
2. Jahoor A, Patel R, Bryan A et al. Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer. J. Bacteriol. 2008; 190: 4408-15.
3. Okada M, Yan SF, Pinsky DJ. Peroxisome proliferator-activated receptor activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEBJ 2002; 16: 1861-8.
4. Eun CS, Han DS, Lee SH et al. Attenuation of colonic inflammation by PPAR gamma in intestinal epithelial cells: effect on Tolllike receptor pathway. Dig. Dis. Sci. 2006; 51: 693-7.
5. Nencioni A, Wesselborg S, Brossart P. Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses. Crit. Rev. Immunol. 2003; 23: 1213-9.
6. Woerly G, Honda K, Loyens M et al. Peroxisome proliferatoractivated receptor and down-regulate allergic inflammation and eosinophil activation. J. Exp.Med. 2003; 198: 411-21.
7. Benayoun L, Letuve S, Druilhe A et al. Regulation of peroxisome proliferator-activated receptor expression in human asthmatic airways. Am. J. Respir. Crit. Care Med. 2001; 164: 1487-94.
8. Kliewer SA, Forman BM, Blumberg B et al. Differential expression and activation of a family of murine PPARs. Proc.Natl Acad. Sci. U S A 1994; 91: 7355-9.
9. Spears M, McSharry C, Thomson NC. Peroxisome proliferatoractivated receptor-gamma agonists as potential antiinflammatory agents in asthma and chronic obstructive pulmonary disease. Clin. Exp. Allergy 2006; 36: 1494-504.
10. Kaplan JM, Cook JA, Hake PW et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 2005; 24: 59-65.
11. Spears M, Donnelly I, Jolly L et al. Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin. Pharmacol. Ther. 2009; 86: 49-53.
12. Perros F, Lambrecht BN, Hammad H. TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways. Respir. Res. 2011; 12: 125. doi: 10.1186/1465-9921-12-125.
13. Piao W, Song C, Chen H et al. Endotoxin tolerance dysregulates MyD88-and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 2009; 86: 863-75.
14. Zhang LL, Gao CY, Fang CQ et al. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc. Res. 2011; 92: 484-93.
15. Wu Y, Zhao XD, Zhuang Z et al. Peroxisome proliferatoractivated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells. Brain Res. 2010; 1322: 102-8.
16. Ji Y, Liu J, Wang Z et al. PPAR gamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. Lab Invest. 2009; 89: 887-902.
17. Ct method. Methods 2001; 25: 402-8.
18. Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr.Drug Targets Inflamm.Allergy 2005; 4: 619-25.
19. Xu X, Wang H, Wang Z et al. Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells. Exp. Lung Res. 2009; 35: 795-805.
20. Simon DM, Arikan MC, Srisuma S et al. Epithelial cell PPAR[gamma] contributes to normal lung maturation. FASEB J. 2006; 20: 1507-9.
21. Park YS, Lillehoj EP, Kato K et al. PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism. Am. J. Physiol. Lung Cell.Mol. Physiol. 2012; 302: L679-87.
22. Park YS, Guang W, Blanchard TG et al. Suppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ. Am. J. Physiol. Gastrointest. Liver Physiol. 2012; 303: G765-74.
23. Belvisi MG, Mitchell JA. Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br. J. Pharmacol. 2009; 158: 994-1003.
24. Schachtrup C, Scholzen TE et al. L-FABP is exclusively expressed in alveolar macrophages within the myeloid lineage: evidence for PPAR α-independent expression. Int. J. Biochem. Cell Biol. 2004; 36: 2042-53.
25. Zhou J, Eksioglu EA, Fortenbery NR et al. Bone marrow mononuclear cells up-regulate toll-like receptor expression and produce inflammatory mediators in response to cigarette smoke extract. PLoS ONE 2011; 6: e21173.
26. Balistreri CR, Candore G, Listì F et al. Role of TLR4 polymorphisms in inflammatory responses: implications for unsuccessful aging. Ann. N. Y. Acad. Sci. 2007; 1119: 203-7.
27. Pace E, Ferraro M, Minervini MI et al. Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS ONE 2012; 7: e33601.
28. MacRedmond RE, Greene CM, Dorscheid DR et al. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir. Res. 2007; 8: 84. doi: 10.1186/1465-9921-8-84.
29. Piao W, Song C, Chen H et al. Endotoxin tolerance dysregulates MyD88-and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 2009; 86: 863-75.
30. Dasu MR, Park S, Devaraj S, Jialal I. Pioglitazone inhibits Toll-like receptor expression and activity in humanmonocytes and db/db mice. Endocrinology 2009; 150: 3457-64.
31. Gurley C, Nichols J, Liu S et al. Microglia and astrocyte activation by Toll-like receptor ligands: modulation by PPAR-gamma agonists. PPAR Res. 2008; 2008: 453120. doi: 10.1155/2008/ 453120.
32. Dubuquoy L, Jansson EA, Deeb S et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003; 124: 1265-76.
33. Castrillo A, Tontonoz P. Nuclear receptors in macrophage biology the crossroads of lipid metabolism and inflammation. Annu. Rev. Cell Dev. Biol. 2004; 20: 455-80.
34. Michelsen KS, Doherty TM, Shah PK et al. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 2004; 173: 5901-7.